NCT05293795

Brief Summary

To determine whether 3D models of fetus' face created from 3D ultrasound will increase maternal and paternal attachment, lower stress, anxiety and depression and have improved life-style choices during pregnancy in African-American women.One-third of participants will receive 3D model and complete questionnaires, one-third will receive a picture of 3D ultrasound of their baby and complete questionnaires, and one-third will only complete the questionnaires

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

March 15, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

March 24, 2022

Status Verified

March 1, 2022

Enrollment Period

2.8 years

First QC Date

March 15, 2022

Last Update Submit

March 15, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Maternal Antenatal Attachment Scale (MAAS)

    The MAAS is a 19 item questionnaire measuring maternal-fetal attachment. Each item has five answer choices scored from 1 low attachment to 5 high attachment such that the total score ranges from 19 to 95. The measure also includes two subscales: (1) Quality of Attachment has 10 items with a range of 10-50 and measures the quality of the mother's attachment to her fetus. (2) Time measures the time spent in attachment mode (or intensity of preoccupation) and consists of 8 items for a range of 8 to 40. (for clarity one item included in the total score is not included in either subscale.)

    5 minutes

  • Maternal Anxiety

    7-question Generalized Anxiety Disorder questionnaire (GAD-7) will be administered

    3 minutes

  • Maternal Depression

    9-question Patient Health Questionnaire (PHQ-9) will be administered

    3 minutes

  • Maternal Stress

    11-question Pregnancy-Related Anxiety Questionnaire-Revised (PRAQ-R2) will be administered.

    3 minutes

Study Arms (3)

3d printed model

ACTIVE COMPARATOR

Mother r is given 3D printed model of fetus' face

Behavioral: 3D printed model

Placebo

PLACEBO COMPARATOR

Mother is given printed picture of 3D ultrasound of fetus

Behavioral: Placebo

Control

NO INTERVENTION

Standard of Care

Interventions

Mother is given 3D printed model of fetus' face

3d printed model
PlaceboBEHAVIORAL

Mother is given a picture of 3D ultrasound of fetus

Placebo

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemale gender assigned at birth only
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age - Female 19-45 years of age
  • Fluent in English
  • African American
  • Currently pregnant (between 26- and 31-weeks' gestation)
  • Have normal 20-week ultrasound

You may not qualify if:

  • Having received more than 3 ultrasounds prior to study
  • Medical need for additional ultrasounds
  • Multiple fetuses
  • \> 31 weeks gestation
  • Is not African American
  • Is not fluent in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Creighton University

Omaha, Nebraska, 68178, United States

RECRUITING

Study Officials

  • Megan Kalata, MD, MPH

    Creighton University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Megan Kalata, MD, MPH

CONTACT

Caroline Nubel, MHM

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: 3D ultrasound and picture of ultrasound or 3D ultrasound and printed model of fetal face and normal controls
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2022

First Posted

March 24, 2022

Study Start

March 1, 2022

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

March 24, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations